Profit & Loss

  • Company Name :
Indegene Ltd Industry : (Healthcare)
  • BSE Code:
  • 544172
  • NSE Symbol:
  • INDGN
  • P/E(TTM):
  • 82.60
  • ISIN Demat:
  • INE065X01017
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 7.36
  • Book Value(₹):
  • 74.10
  • Market Cap(₹Cr.):
  • 14,547.68
  • Face Value(₹):
  • 2.00
Particulars Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
INCOME :          
Sales Turnover 1,045.60 1,005.70 836.70 511.00 334.50
Excise Duty - - - - -
Net Sales 1,045.60 1,005.70 836.70 511.00 334.50
Other Income 50.30 36.80 27.80 63.60 20.10
Stock Adjustments - - - - -
Total Income 1,095.90 1,042.50 864.50 574.60 354.60
EXPENDITURE :          
Raw Materials - - - - -
Power and Fuel Cost - - 1.10 1.00 2.00
Other Manufacturing Expenses 63.40 60.00 98.30 62.50 35.70
Selling and Administration Expenses 53.40 57.80 37.00 18.60 21.90
Miscellaneous Expenses 8.50 8.80 5.60 39.10 45.70
Employee Benefit Expenses 752.30 701.20 526.00 273.00 187.00
Less: Preoperative Expenditure - - - - -
Total Expenses - - - - -
Operating Profit 218.30 214.70 196.50 180.40 62.30
Interest 6.60 6.40 3.00 3.50 3.40
Gross Profit 211.70 208.30 193.50 176.90 58.90
Depreciation 31.10 31.70 23.60 17.60 13.40
Profit Before Tax 180.60 176.60 169.90 159.30 45.50
Current Tax 44.30 49.70 28.80 28.60 15.40
Fringe Benefit tax - - - - -
Deferred Tax -1.60 -3.30 8.40 -1.70 -1.60
Reported Net Profit 137.90 130.20 132.70 132.40 31.70
Extraordinary Items 13.36 - - 2.46 -28.91
Adjusted Net Profit 124.54 130.20 132.70 129.94 60.61
Adjustment below Net Profit - 0.70 -2.80 126.60 -
Profit/Loss Balance carried down 493.80 362.90 233.00 -24.00 -55.70
Statutory Appropriations - - - - -
Appropriations - - - - -
P & L Balance carried down 631.70 493.80 362.90 235.00 -24.00
Dividend - - - - -
Preference Dividend - - - - -
Equity Dividend (%) - - - - -
Dividend Per Share(Rs) - - - - -
Earnings Per Share-Unit Curr 6.21 5.88 663.50 882.67 211.33
Earnings Per Share(Adj)-Unit Curr - - - - -
Book Value 42.96 35.91 3,250.00 1,692.67 -20.67
Book Value(Adj)-Unit Curr - - - - -